• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HeartSciences Inc. - Common Stock (NQ:HSCS)

3.280 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about HeartSciences Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
December 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025
Version 1.1 Designed to Provide Best Usability of any ECG System 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
September 11, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Conference Participation and Investor Webinar
August 15, 2025
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 04, 2025
Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
June 03, 2025
Patent covers estimation of measures of heart function using an ECG, which are critical in the diagnosis and early detection of heart disease 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
May 20, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
May 08, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
May 07, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
May 01, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
March 13, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
March 10, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
December 16, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
November 13, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
September 12, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
September 12, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
July 29, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
July 26, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
July 25, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 11, 2024
Further expands HeartSciences extensive patent portfolio 
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Regains Compliance with Nasdaq Listing Requirements
June 04, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
May 20, 2024
Granted Indian Patent for its MyoVista® Wavelet Technology 
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
April 24, 2024
Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease 
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences to Present at the LD Micro Invitational XIV Conference
April 02, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
March 26, 2024
Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be Recommended 
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
March 14, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap